These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues. Rapti I; Hadziyannis S World J Hepatol; 2015 May; 7(8):1064-73. PubMed ID: 26052395 [TBL] [Abstract][Full Text] [Related]
3. Management of viral hepatitis B. Pramoolsinsup C J Gastroenterol Hepatol; 2002 Feb; 17 Suppl():S125-45. PubMed ID: 12000599 [TBL] [Abstract][Full Text] [Related]
4. Prevention of hepatocellular carcinoma in hepatitis B virus infection. Lim SG; Mohammed R; Yuen MF; Kao JH J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903 [TBL] [Abstract][Full Text] [Related]
6. T-cell therapy for chronic viral hepatitis. Bertoletti A; Tan AT; Koh S Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469 [TBL] [Abstract][Full Text] [Related]
7. Review article: the prevention of hepatitis B-related hepatocellular carcinoma. Lin CL; Kao JH Aliment Pharmacol Ther; 2018 Jul; 48(1):5-14. PubMed ID: 29722445 [TBL] [Abstract][Full Text] [Related]
8. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets. Ringelhan M; O'Connor T; Protzer U; Heikenwalder M J Pathol; 2015 Jan; 235(2):355-67. PubMed ID: 25196558 [TBL] [Abstract][Full Text] [Related]
9. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. ; J Hepatol; 2017 Aug; 67(2):370-398. PubMed ID: 28427875 [TBL] [Abstract][Full Text] [Related]
10. Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma? Lok AS J Gastroenterol Hepatol; 2011 Feb; 26(2):221-7. PubMed ID: 21070361 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the cost-effectiveness of entecavir versus lamivudine in hepatitis BeAg-positive chronic hepatitis B patients. Yuan Y; Iloeje UH; Hay J; Saab S J Manag Care Pharm; 2008; 14(1):21-33. PubMed ID: 18240879 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis B Virus (HBV) Infection and Hepatocellular Carcinoma- New Insights for an Old Topic. Yan SY; Fan JG; Qio L Curr Cancer Drug Targets; 2017; 17(6):505-511. PubMed ID: 27677954 [TBL] [Abstract][Full Text] [Related]
13. Impact of HBV therapy on the incidence of hepatocellular carcinoma. Triolo M; Della Corte C; Colombo M Liver Int; 2014 Feb; 34 Suppl 1():139-45. PubMed ID: 24373091 [TBL] [Abstract][Full Text] [Related]
14. [Hepatocellular carcinoma, hepatitis B virus and the immune system]. Grob PJ Schweiz Med Wochenschr; 1986 Aug; 116(34):1133-45. PubMed ID: 3020684 [TBL] [Abstract][Full Text] [Related]
15. Antiviral therapy for chronic hepatitis B: a review. Hanazaki K Curr Drug Targets Inflamm Allergy; 2004 Mar; 3(1):63-70. PubMed ID: 15032642 [TBL] [Abstract][Full Text] [Related]
16. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma. Kubo S; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Nozawa A; Kinoshita M; Hamano G; Ito T; Urata Y World J Gastroenterol; 2015 Jul; 21(27):8249-55. PubMed ID: 26217076 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus genotypes and hepatocellular carcinoma in Taiwan. Kao JH Intervirology; 2003; 46(6):400-7. PubMed ID: 14688459 [TBL] [Abstract][Full Text] [Related]